The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Abstract
Background — Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction. Methods and Results — In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P =0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P =0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths. Conclusions — The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“contemporary high-intensity statin formulations achieve greater low-density lipoprotein–lowering effects and cardiovascular endpoint reduction than were used during the first mixed EPA/DHA trials, such as GISSI-P.17,27,44”
From Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality (2025) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“Data from meta-analyses suggest that a reduction of calculated glomerular filtration rate (GFR) does not reflect any adverse effects on kidney function [315].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“Results from other meta-analyses suggest reduced major CVD events in patients with high TGs and low HDL-C in fibrate-treated patients, but no decrease in CVD or total mortality [314-316].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“A post hoc subgroup analysis revealed that this reduction in mortality and SCD was concentrated in the approximately 2000 patients with reduced left ventricular ejection fraction [67].”
From Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health (2022) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
(1999) · PubMed · Cited by 2,062
Self-citationn-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 950
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Research works printed but not linked: 10
Cited by
Sorted by citations
Items 101–200 of 1,000
Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A., Capps, N., Davey Smith, G., Riemersma, R., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub2 · Cited by 264
Fruchart, J.-C., Sacks, F. M., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.046 · Cited by 260
Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial
Kiecolt‐Glaser, J. K., Epel, E. S., Belury, M. A., Andridge, R., Lin, J., Glaser, R., Malarkey, W. B., Hwang, B. S., & Blackburn, E. H. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.09.004 · Cited by 265
Ziouzenkova, O., Perrey, S., Asatryan, L., Hwang, J., MacNaul, K. L., Moller, D. E., Rader, D. J., Sevanian, A., Zechner, R., Höefler, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538015100 · Cited by 254
Omega-3 Fatty Acids for Cardioprotection
Lee, J. H., O’Keefe, J. H., Lavie, C. J., Marchioli, R., & Harris, W. S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.324 · Cited by 251
Self-citationHighly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
Tanaka, N., Sano, K., Horiuchi, A., Tanaka, E., Kiyosawa, K., & Aoyama, T. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815591aa · Cited by 248
The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease
Ruiz-Núñez, B., Dijck-Brouwer, J., & Muskiet, F. A. J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.007 · Cited by 249
Cawood, A. L., Ding, R., Napper, F. L., Young, R. H., Williams, J. A., Ward, M. J., Gudmundsen, O., Vige, R., Payne, S. P. K., Ye, S., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.022 · Cited by 249
Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8677 · Cited by 241
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Self-citationSeafood Consumption and Components for Health
Hosomi, R., Yoshida, M., & Fukunaga, K. (2012) · Global Journal of Health Science · doi:10.5539/gjhs.v4n3p72 · Cited by 248
Changes in the quality of fish oils due to storage temperature and time
Boran, G., Karaçam, H., & Boran, M. (2005) · Food Chemistry · doi:10.1016/j.foodchem.2005.06.041 · Cited by 237
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., Hwang, B. S., & Glaser, R. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.011 · Cited by 233
Martens, E., de Jonge, P., Na, B., Cohen, B., Lett, H., & Whooley, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.74 · Cited by 228
Dietary α-Linolenic Acid Intake and Risk of Sudden Cardiac Death and Coronary Heart Disease
Albert, C. M., Oh, K., Whang, W., Manson, J. E., Chae, C. U., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · Circulation · doi:10.1161/circulationaha.105.572008 · Cited by 231
Fish Oil and Postoperative Atrial Fibrillation
Mozaffarian, D., Marchioli, R., Macchia, A., Silletta, M. G., Ferrazzi, P., Gardner, T. J., Latini, R., Libby, P., Lombardi, F., O’Gara, P. T., et al. (2012) · JAMA · doi:10.1001/jama.2012.28733 · Cited by 230
Self-citationThe Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
Omega-3 fatty acids: cardiovascular benefits, sources and sustainability
Lee, J. H., O’Keefe, J. H., Lavie, C. J., & Harris, W. S. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.188 · Cited by 231
Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
Serhan, C. N. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200503000-00003 · Cited by 227
Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G., von Andrian, U. H., & Serhan, C. N. (2008) · Blood · doi:10.1182/blood-2007-11-122598 · Cited by 228
Troesch, B., Eggersdorfer, M. L., Laviano, A., Rolland, Y., Smith, A. D., Warnke, I., Weimann, A., & Calder, P. C. (2020) · Nutrients · doi:10.3390/nu12092555 · Cited by 242
Relationships between plasma fatty acid composition and coronary artery disease.
Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5876 · Cited by 218
Effects of fish-oil supplementation on myocardial fatty acids in humans
Metcalf, R. G., James, M. J., Gibson, R. A., Edwards, J. R. M., Stubberfield, J., Stuklis, R. G., Roberts‐Thomson, K. C., Young, G. D., & Cleland, L. G. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1222 · Cited by 221
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review
Lee, K. W., & Lip, G. Y. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2368 · Cited by 217
Fischer, R., Konkel, A., Mehling, H., Blossey, K., Gapelyuk, A., Wessel, N., von Schacky, C., Dechend, R., Müller, D. N., Rothe, M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047357 · Cited by 219
He, K. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.06.003 · Cited by 216
The science behind dietary omega-3 fatty acids
Surette, M. E. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071356 · Cited by 219
Understanding Omega-3 Polyunsaturated Fatty Acids
Calder, P. C., & Yaqoob, P. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.11.2083 · Cited by 214
Antiatherosclerotic and Antithrombotic Effects of Omega-3 Fatty Acids
Robinson, J. G., & Stone, N. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.026 · Cited by 207
Omega-3 fatty acids and cardiovascular disease
von Schacky, C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3280127af0 · Cited by 207
What is the evidence for a role for diet and nutrition in osteoarthritis?
Thomas, S. J., Browne, H., Mobasheri, A., & Rayman, M. P. (2018) · Rheumatology · doi:10.1093/rheumatology/key011 · Cited by 212
Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet
Kuipers, R. S., Luxwolda, M. F., Dijck-Brouwer, J., Eaton, S. B., Crawford, M. A., Cordain, L., & Muskiet, F. A. J. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510002679 · Cited by 209
Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women
Chiuve, S. E., Fung, T. T., Rexrode, K. M., Spiegelman, D. L., Manson, J. E., Stampfer, M. J., & Albert, C. M. (2011) · JAMA · doi:10.1001/jama.2011.907 · Cited by 208
Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., & Pratt, C. M. (2010) · JAMA · doi:10.1001/jama.2010.1735 · Cited by 201
Erkkilä, A. T., Lehto, S., Pyörälà, K., & Uusitupa, M. I. J. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.65 · Cited by 201
The Omega-3 Fatty Acid Nutritional Landscape: Health Benefits and Sources
Deckelbaum, R. J., & Torrejón, C. (2012) · Journal of Nutrition · doi:10.3945/jn.111.148080 · Cited by 206
Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids
Konkel, A., & Schunck, W.-H. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.09.009 · Cited by 227
Harris, W. S., Kris‐Etherton, P. M., & Harris, K. A. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0078-z · Cited by 200
Schunck, W., Konkel, A., Fischer, R., & Weylandt, K. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.016 · Cited by 211
Linoleic acid: Between doubts and certainties
Choque, B., Catheline, D., Rioux, V., & Legrand, P. (2013) · Biochimie · doi:10.1016/j.biochi.2013.07.012 · Cited by 198
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
A Quantitative Analysis of Fish Consumption and Coronary Heart Disease Mortality
König, A., Bouzan, C., Cohen, J. T., We, C., Kris‐Etherton, P. M., Gray, G. C., LAWRENCE, R., Savitz, D. A., & Teutsch, S. M. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.07.001 · Cited by 192
Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?
Bowen, K. J., Harris, W. S., & Kris‐Etherton, P. M. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0487-1 · Cited by 202
EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
Block, R., Harris, W. S., Reid, K. J., Sands, S. A., & Spertus, J. A. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.042 · Cited by 190
Griffin, M., Sanders, T. A. B., Davies, I. G., Morgan, L., Millward, D. J., Lewis, F., Slaughter, S. L., Cooper, J. A., Miller, G. J., & Griffin, B. A. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.6.1290 · Cited by 190
Relative Intake of Macronutrients Impacts Risk of Mild Cognitive Impairment or Dementia
Roberts, R. O., Roberts, L. A., Geda, Y. E., Cha, R. H., Pankratz, V. S., O’Connor, H. M., Knopman, D. S., & Petersen, R. C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120862 · Cited by 194
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, F. O., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub2 · Cited by 194
Fish and n−3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death
Mozaffarian, D. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1991s · Cited by 181
Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes
Djoussé, L., Gaziano, J. M., Buring, J. E., & Lee, I.-M. M. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005603 · Cited by 186
Novel ? ? 3-derived local mediators in anti-inflammation and resolution
NSERHAN, C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.09.002 · Cited by 184
Mason, R. P., Jacob, R. F., Shrivastava, S., Sherratt, S. C. R., & Chattopadhyay, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.10.002 · Cited by 179
The Pickering Lecture British Hypertension Society, 10th September 2002
Harrison, D. G., Cai, H. “., Landmesser, U., & Griendling, K. K. (2003) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2003.014 · Cited by 206
Polyunsaturated fatty acids and their effects on cardiovascular disease.
Ander, B. P., Dupasquier, C. M. C., Prociuk, M. A., & Pierce, G. N. (2003) · PubMed Central · Cited by 178
Microalgae as Sources of Omega-3 Polyunsaturated Fatty Acids: Biotechnological Aspects
Barta, D. G., Coman, V., & Vodnar, D. C. (2021) · Algal Research · doi:10.1016/j.algal.2021.102410 · Cited by 178
Mozaffarian, D., Marfisi, R., Levantesi, G., Silletta, M. G., Tavazzi, L., Tognoni, G., Valagussa, F., & Marchioli, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61343-9 · Cited by 179
Self-citationThe role of omega-3 fatty acids in the secondary prevention of cardiovascular disease
Lee, K. W., & Lip, G. Y. H. (2003) · QJM · doi:10.1093/qjmed/hcg092 · Cited by 176
Drug Therapy for Hypercholesterolemia and Dyslipidemia
de Ferranti, S. D. (2007) · Springer eBooks · doi:10.1007/978-1-84628-953-8_13 · Cited by 175
Serhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 176
Brouwer, I. A., Heeringa, J., Geleijnse, J. M., Zock, P. L., & Witteman, J. C. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.029 · Cited by 175
Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research
London, B., Albert, C. M., Anderson, M. E., Giles, W. R., Wagoner, D. R. V., Balk, E. M., Billman, G. E., Chung, M., Lands, W. E. M., Leaf, A., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.712984 · Cited by 176
Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction
Heydari, B., Abdullah, S. M., Pottala, J. V., Shah, R. V., Abbasi, S. A., Mandry, D., Francis, S. A., Lumish, H. S., Ghoshhajra, B. B., Hoffmann, U., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019949 · Cited by 175
Kremmyda, L.-S., TVRZICKÁ, E., Staňková, B., & Žák, A. (2011) · Biomedical Papers · doi:10.5507/bp.2011.052 · Cited by 181
Frost, L., & Vestergaard, P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.50 · Cited by 172
Prevention of sudden cardiac death by n−3 polyunsaturated fatty acids
Leaf, A., Xiao, Y.-F., Kang, J. X., & Billman, G. E. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00039-1 · Cited by 172
Fotuhi, M., Mohassel, P., & Yaffe, K. (2009) · Nature Reviews Neurology · doi:10.1038/ncpneuro1044 · Cited by 344
Block, G., Jensen, C. D., Norkus, E. P., Dalvi, T. B., Wong, L. G., McManus, J. F., & Hudes, M. L. (2007) · Nutrition Journal · doi:10.1186/1475-2891-6-30 · Cited by 170
Farzaneh‐Far, R., Harris, W. S., Garg, S. K., Na, B., & Whooley, M. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.013 · Cited by 174
The two faces of the 15-lipoxygenase in atherosclerosis
Wittwer, J., & Hersberger, M. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.08.001 · Cited by 174
Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels
Elinder, F., & Liin, S. I. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00043 · Cited by 178
The Role of Fish Oils in the Treatment of Rheumatoid Arthritis
Cleland, L. G., James, M. J., & Proudman, S. (2003) · Drugs · doi:10.2165/00003495-200363090-00001 · Cited by 160
Logan, A. C. (2003) · PubMed · Cited by 163
Oxidation of Marine Omega-3 Supplements and Human Health
Albert, B. B., Cameron‐Smith, D., Hofman, P. L., & Cutfield, W. S. (2013) · BioMed Research International · doi:10.1155/2013/464921 · Cited by 177
Harris, W. S., Pottala, J. V., Varvel, S. A., Borowski, J., Ward, J. N., & McConnell, J. P. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.12.004 · Cited by 167
Fredman, G., & Serhan, C. N. (2011) · Biochemical Journal · doi:10.1042/bj20110327 · Cited by 162
Matsuzaki, M., Yokoyama, M., Saitō, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1197 · Cited by 157
Micallef, M. A., & Garg, M. L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.020 · Cited by 159
Cytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids
Arnold, C., Konkel, A., Fischer, R., & Schunck, W.-H. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70311-x · Cited by 174
Antiarrhythmic effects of omega-3 fatty acids
Reiffel, J. A., & McDonald, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.027 · Cited by 153
Casula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(13)70005-9 · Cited by 152
Shearer, G. C., Harris, W. S., Pedersen, T. L., & Newman, J. W. I. (2009) · Journal of Lipid Research · doi:10.1194/m900193-jlr200 · Cited by 155
Omega-3 Index and Cardiovascular Health
von Schacky, C. (2014) · Nutrients · doi:10.3390/nu6020799 · Cited by 166
Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153
Role of n−3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease
Jacobson, T. A. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1981s · Cited by 147
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, F. O., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub3 · Cited by 151
Calcium and Cardiac Arrhythmias: DADs, EADs, and Alternans
Clusin, W. T. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609356 · Cited by 146
Lifestyle-related factors in predementia and dementia syndromes
Solfrizzi, V., Capurso, C. A., D’Introno, A., Colacicco, A. M., Santamato, A., Ranieri, M., Fiore, P., Capurso, A., & Panza, F. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.133 · Cited by 155
Multiple sclerosis and nutrition
Schwarz, S. T., & Leweling, H. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1119oa · Cited by 151
Review of the Effects of Omega-3 Supplementation in Dialysis Patients
Friedman, A. N., & Moe, S. M. (2005) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00740805 · Cited by 142
Harris, W. S., Tintle, N., Etherton, M. R., & Vasan, R. S. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.02.010 · Cited by 149
Zhang, Z., Fulgoni, V. L. I., Kris‐Etherton, P. M., & Mitmesser, S. H. (2018) · Nutrients · doi:10.3390/nu10040416 · Cited by 142
The Omega-3 Index: Clinical Utility for Therapeutic Intervention
Harris, W. S. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0141-6 · Cited by 147
Omega-3 fatty acids and major depression: A primer for the mental health professional
Logan, A. C. (2004) · Lipids in Health and Disease · doi:10.1186/1476-511x-3-25 · Cited by 142
Sakabe, M., Shiroshita-Takeshita, A., Maguy, A., Dumesnil, C., Nigam, A., Leung, T. K., & Nattel, S. (2007) · Circulation · doi:10.1161/circulationaha.107.704759 · Cited by 138
Fatty acids and the immune system: from basic science to clinical applications
Yaqoob, P. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2003328 · Cited by 140
Triglycerides and HDL Cholesterol
Bitzur, R., Cohen, H., Kamari, Y., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s343 · Cited by 132
Fish Consumption Is Associated With Lower Heart Rates
Dallongeville, J., Yarnell, J., Ducimetière, P., Arveiler, D., Ferrières, J., Montaye, M., Luc, G., Evans, A., Bingham, A., Hass, B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000084542.64687.97 · Cited by 140
Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation
Macchia, A., Grancelli, H., Varini, S. D., Nul, D. R., Laffaye, N., Mariani, J. A., Ferrante, D., Badra, R., Figal, J. C., Ramos, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.021 · Cited by 140
Self-citationLong-chain omega-3 fatty acids: time to establish a dietary reference intake
Flock, M. R., Harris, W. S., & Kris‐Etherton, P. M. (2013) · Nutrition Reviews · doi:10.1111/nure.12071 · Cited by 141
Chilton, F. H., Dutta, R., Reynolds, L. M., Sergeant, S., Mathias, R. A., & Seeds, M. C. (2017) · Nutrients · doi:10.3390/nu9111165 · Cited by 140
Metadata
- Authors
- Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., & Valagussa, F.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G...
- Corresponding author
- Marchioli, Roberto
- Venue
- Circulation
- Published
- 2002-04-23
- Volume
- 105
- Issue
- 16
- Pages
- 1897-1903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128788220
- Cited by
- 1,311
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 21 · 2021: 17 · 2020: 30 · 2019: 20 · 2018: 33 · 2017: 42 · 2016: 42 · 2015: 49 · 2014: 64 · 2013: 87 · 2012: 84
- FWCI
- 60.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- omega-3 fatty acids, myocardial infarction, sudden death, mortality, vitamin E, antiarrhythmic effect, time course of treatment effects, cardiovascular mortality, coronary artery disease, cerebrovascular events
- MeSH terms
- Anti-Arrhythmia Agents, Female, Follow-Up Studies, Humans, Italy, Kinetics, Lipids, Male, Middle Aged, Myocardial Infarction, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
